Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate

Rhoptry proteins have been extensively shown to be important in invasion and parasitophorous vacuole (PV) formation. This work evaluates the immunogenicity and protective efficacy of Plasmodium vivax RAP2 in the non-human Aotus primate model, when expressed as a recombinant molecule in E. coli and f...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23450
Acceso en línea:
https://doi.org/10.1016/j.vaccine.2009.02.083
https://repository.urosario.edu.co/handle/10336/23450
Palabra clave:
Alum hydroxide
Antibody
Clindamycin
Cytokine
Freund adjuvant
Gamma interferon
Immunological adjuvant
Interleukin 2
Interleukin 4
Interleukin 5
Interleukin 6
Malaria vaccine
Primaquine
Pyrimethamine
Quinine sulfate
Recombinant protein pvrap2 vaccine
Recombinant rhoptry associated protein 2 vaccine
Sulfadoxine
Tumor necrosis factor
Unclassified drug
Animal experiment
Animal model
Antibody response
Antibody specificity
Antibody titer
Aotus nancymaae
Article
Cell vacuole
Cellular immunity
Controlled study
Cytokine production
Drug efficacy
Enzyme linked immunosorbent assay
Escherichia coli
Humoral immunity
Immune response
Immunization
Immunofluorescence
Immunogenicity
Monkey
Nonhuman
Parasitemia
Plasmodium vivax
Priority journal
Protection
Protein expression
Western blotting
Animals
Aotidae
Immunogenetic processes
Malaria vaccines
Plasmodium vivax
Protozoan proteins
Immune response
Plasmodium vivax
Rhoptry-associated protein
Vaccine candidate
animal
Disease models
Rights
License
Abierto (Texto Completo)
Description
Summary:Rhoptry proteins have been extensively shown to be important in invasion and parasitophorous vacuole (PV) formation. This work evaluates the immunogenicity and protective efficacy of Plasmodium vivax RAP2 in the non-human Aotus primate model, when expressed as a recombinant molecule in E. coli and formulated in Freund and Alum hydroxide adjuvants. Our results show that rPvRAP2 is immunogenic in both formulations, finding a trend of higher cytokine levels in immunized monkeys, specially in IL-4 levels (using Freund's adjuvant) and IL-5 (using Alum hydroxide). RAP2 is suggested as a P. vivax-vaccine candidate since immunized monkeys exhibited lower parasitemias than control groups after being experimentally challenged with the P. vivax VCG-I strain. © 2009 Elsevier Ltd. All rights reserved.